A preliminary follow-up study on irreversible electroporation therapy in older patients with prostate cancer
Abstract Background Prostate cancer is a prevalent condition among older males, with radical prostatectomy being the standard treatment. However, this procedure can inevitably impact urinary and sexual functions. Irreversible electroporation represents an innovative therapeutic approach that employs...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-03-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-02025-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850028063965839360 |
|---|---|
| author | Zhi-Yu Xia Jun Yang Fan Xiao Jin-Zhou Xu Xing-Yu Zhong Shao-Gang Wang Qi-Dong Xia |
| author_facet | Zhi-Yu Xia Jun Yang Fan Xiao Jin-Zhou Xu Xing-Yu Zhong Shao-Gang Wang Qi-Dong Xia |
| author_sort | Zhi-Yu Xia |
| collection | DOAJ |
| description | Abstract Background Prostate cancer is a prevalent condition among older males, with radical prostatectomy being the standard treatment. However, this procedure can inevitably impact urinary and sexual functions. Irreversible electroporation represents an innovative therapeutic approach that employs high-voltage electrical pulses to selectively eradicate tumor cells, potentially preserving vital normal tissue. Materials and methods This follow-up study included 11 older prostate cancer patients who underwent IRE therapy from November 2021 to December 2023. The cohort was aged 66–77 years with a median preoperative PSA of 9.46 ng/mL. Based on the EAU risk groups classification, patients were divided into low (n = 4), intermediate (n = 6), and high-risk (n = 1) groups. Follow-up exams were conducted every 3 to 6 months to assess PSA levels, imaging, and urinary/sexual function. Results Postoperatively, there was a significant decline in PSA levels across all patients, with a mean nadir of 0.78 ng/mL. The cumulative clinically significant prostate cancer recurrence rate was 27.3% at 30 months. Complications included urinary issues in 3 patients (27.3%), urethral pain in 2 patients (18.2%), and sexual dysfunction in 1 patient (9.1%). Conclusion This study suggests that IRE therapy is a safe and effective treatment option for older prostate cancer patients, with promising results in preserving urinary and sexual functions. However, the recurrence rate is higher than historical controls, indicating the need for further research to optimize treatment outcomes. |
| format | Article |
| id | doaj-art-282807bb7cde49c78d0d56fd0a3617d4 |
| institution | DOAJ |
| issn | 2730-6011 |
| language | English |
| publishDate | 2025-03-01 |
| publisher | Springer |
| record_format | Article |
| series | Discover Oncology |
| spelling | doaj-art-282807bb7cde49c78d0d56fd0a3617d42025-08-20T02:59:57ZengSpringerDiscover Oncology2730-60112025-03-011611810.1007/s12672-025-02025-0A preliminary follow-up study on irreversible electroporation therapy in older patients with prostate cancerZhi-Yu Xia0Jun Yang1Fan Xiao2Jin-Zhou Xu3Xing-Yu Zhong4Shao-Gang Wang5Qi-Dong Xia6Department and Institute of of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment and Institute of of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment and Institute of of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment and Institute of of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment and Institute of of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment and Institute of of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment and Institute of of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyAbstract Background Prostate cancer is a prevalent condition among older males, with radical prostatectomy being the standard treatment. However, this procedure can inevitably impact urinary and sexual functions. Irreversible electroporation represents an innovative therapeutic approach that employs high-voltage electrical pulses to selectively eradicate tumor cells, potentially preserving vital normal tissue. Materials and methods This follow-up study included 11 older prostate cancer patients who underwent IRE therapy from November 2021 to December 2023. The cohort was aged 66–77 years with a median preoperative PSA of 9.46 ng/mL. Based on the EAU risk groups classification, patients were divided into low (n = 4), intermediate (n = 6), and high-risk (n = 1) groups. Follow-up exams were conducted every 3 to 6 months to assess PSA levels, imaging, and urinary/sexual function. Results Postoperatively, there was a significant decline in PSA levels across all patients, with a mean nadir of 0.78 ng/mL. The cumulative clinically significant prostate cancer recurrence rate was 27.3% at 30 months. Complications included urinary issues in 3 patients (27.3%), urethral pain in 2 patients (18.2%), and sexual dysfunction in 1 patient (9.1%). Conclusion This study suggests that IRE therapy is a safe and effective treatment option for older prostate cancer patients, with promising results in preserving urinary and sexual functions. However, the recurrence rate is higher than historical controls, indicating the need for further research to optimize treatment outcomes.https://doi.org/10.1007/s12672-025-02025-0Irreversible electroporationProstate cancerFollow-upComplicationsOncological outcomes |
| spellingShingle | Zhi-Yu Xia Jun Yang Fan Xiao Jin-Zhou Xu Xing-Yu Zhong Shao-Gang Wang Qi-Dong Xia A preliminary follow-up study on irreversible electroporation therapy in older patients with prostate cancer Discover Oncology Irreversible electroporation Prostate cancer Follow-up Complications Oncological outcomes |
| title | A preliminary follow-up study on irreversible electroporation therapy in older patients with prostate cancer |
| title_full | A preliminary follow-up study on irreversible electroporation therapy in older patients with prostate cancer |
| title_fullStr | A preliminary follow-up study on irreversible electroporation therapy in older patients with prostate cancer |
| title_full_unstemmed | A preliminary follow-up study on irreversible electroporation therapy in older patients with prostate cancer |
| title_short | A preliminary follow-up study on irreversible electroporation therapy in older patients with prostate cancer |
| title_sort | preliminary follow up study on irreversible electroporation therapy in older patients with prostate cancer |
| topic | Irreversible electroporation Prostate cancer Follow-up Complications Oncological outcomes |
| url | https://doi.org/10.1007/s12672-025-02025-0 |
| work_keys_str_mv | AT zhiyuxia apreliminaryfollowupstudyonirreversibleelectroporationtherapyinolderpatientswithprostatecancer AT junyang apreliminaryfollowupstudyonirreversibleelectroporationtherapyinolderpatientswithprostatecancer AT fanxiao apreliminaryfollowupstudyonirreversibleelectroporationtherapyinolderpatientswithprostatecancer AT jinzhouxu apreliminaryfollowupstudyonirreversibleelectroporationtherapyinolderpatientswithprostatecancer AT xingyuzhong apreliminaryfollowupstudyonirreversibleelectroporationtherapyinolderpatientswithprostatecancer AT shaogangwang apreliminaryfollowupstudyonirreversibleelectroporationtherapyinolderpatientswithprostatecancer AT qidongxia apreliminaryfollowupstudyonirreversibleelectroporationtherapyinolderpatientswithprostatecancer AT zhiyuxia preliminaryfollowupstudyonirreversibleelectroporationtherapyinolderpatientswithprostatecancer AT junyang preliminaryfollowupstudyonirreversibleelectroporationtherapyinolderpatientswithprostatecancer AT fanxiao preliminaryfollowupstudyonirreversibleelectroporationtherapyinolderpatientswithprostatecancer AT jinzhouxu preliminaryfollowupstudyonirreversibleelectroporationtherapyinolderpatientswithprostatecancer AT xingyuzhong preliminaryfollowupstudyonirreversibleelectroporationtherapyinolderpatientswithprostatecancer AT shaogangwang preliminaryfollowupstudyonirreversibleelectroporationtherapyinolderpatientswithprostatecancer AT qidongxia preliminaryfollowupstudyonirreversibleelectroporationtherapyinolderpatientswithprostatecancer |